| 000 | 01767 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513190051.0 | ||
| 264 | 0 | _c19990817 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeith, C P | |
| 245 | 0 | 0 |
_aFrequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. _h[electronic resource] |
| 260 |
_bBlood _cAug 1999 |
||
| 300 |
_a1086-99 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xbiosynthesis |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xbiosynthesis |
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultidrug Resistance-Associated Proteins |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVault Ribonucleoprotein Particles _xgenetics |
| 700 | 1 | _aKopecky, K J | |
| 700 | 1 | _aChen, I M | |
| 700 | 1 | _aEijdems, L | |
| 700 | 1 | _aSlovak, M L | |
| 700 | 1 | _aMcConnell, T S | |
| 700 | 1 | _aHead, D R | |
| 700 | 1 | _aWeick, J | |
| 700 | 1 | _aGrever, M R | |
| 700 | 1 | _aAppelbaum, F R | |
| 700 | 1 | _aWillman, C L | |
| 773 | 0 |
_tBlood _gvol. 94 _gno. 3 _gp. 1086-99 |
|
| 999 |
_c10377908 _d10377908 |
||